During the past decade, Long Beach Memorial Medical Center-Todd Cancer Institute conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 26 clinical trials were completed, i.e. on average, 1300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 14 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Long Beach Memorial Medical Center-Todd Cancer Institute" #1 sponsor was "National Cancer Institute (NCI)" with 11 trials, followed by "Gynecologic Oncology Group" with 6 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "NSABP Foundation Inc" with 3 trials sponsored and "SWOG Cancer Research Network" with 3 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Long Beach Memorial Medical Center-Todd Cancer Institute" #1 collaborator was "National Cancer Institute (NCI)" with 18 trials as a collaborator, "NRG Oncology" with 7 trials as a collaborator, "NSABP Foundation Inc" with 3 trials as a collaborator, "SWOG Cancer Research Network" with 3 trials as a collaborator and "Cancer and Leukemia Group B" with 2 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Long Beach Memorial Medical Center-Todd Cancer Institute" are "Breast Cancer" (11 trials), "Fallopian Tube Endometrioid Adenocarcinoma" (5 trials), "Fallopian Tube Mucinous Adenocarcinoma" (5 trials), "Fallopian Tube Transitional Cell Carcinoma" (5 trials) and "Ovarian Brenner Tumor" (5 trials). Many other conditions were trialed in "Long Beach Memorial Medical Center-Todd Cancer Institute" in a lesser frequency.

Most popular intervention types in "Long Beach Memorial Medical Center-Todd Cancer Institute" are "Drug" (30 trials), "Other" (19 trials), "Biological" (11 trials), "Procedure" (5 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (14 trials), "Paclitaxel" (14 trials), "Quality-of-Life Assessment" (12 trials), "Carboplatin" (8 trials) and "Bevacizumab" (7 trials). Other intervention names were less common.

The vast majority of trials in "Long Beach Memorial Medical Center-Todd Cancer Institute" are 21 trials for "Female" genders and 13 trials for "All" genders.

Currently, there are NaN active trials in "Long Beach Memorial Medical Center-Todd Cancer Institute". undefined are not yet recruiting, undefined are recruiting, 16 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 16 completed trials in Long Beach Memorial Medical Center-Todd Cancer Institute, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Long Beach Memorial Medical Center-Todd Cancer Institute, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".